Press enter to confirm search term

Acne & Acne Scaring Solutions

Energist’s NeoGen, UltraPlus, ePulse and FRX technology can actively improve acne and/or acne scaring, making our equipment a perfect purchase for any clinic.

acne1
acne2

Acne is caused when pores become blocked by over production of sebum and dead skin cells. Once pores are blocked bacteria can build up and cause infection. This can result in acne.

Energist pulsed light treatments (VPL & IPL) improve active acne by using the body’s natural defences to destroy the anaerobic bacteria that causes the infection. Energist pulsed light also effectively reduces the inflammation associated with acne.

Acne is reduced significantly following a course of treatments and skin texture and tone is improved as the light energy initiates further collagen production.

When it comes to light-based acne management, UK Manufacturer Energist Medical Group is a name you can trust – We have been designing and manufacturing VPL and IPL systems for more than 15 years – and our treatments are backed up by a number of clinical studies.

All of our laser & pulsed light systems, which are used by professionals worldwide, are FDA cleared and pass stringent testing and inspections in order to be badged as CE marked medical products.

How it works

Skin naturally produces a chemical caused porphyrin to fight the internal bacteria that causes acne. Scientists have discovered that specific wavelengths of light stimulate the body’s production of porphyrin and dramatically reduce acne by breaking down the bacteria through the production of singlet oxygen.

acneimage

Energist pulsed light systems produce the ideal wavelengths to stimulate the production of porphyrin and thus destroying the anaerobic bacteria that causes the infection by producing an oxygen rich environment.

Energist pulsed light also effectively reduces the inflammation associated with acne through the delivery of red light, which is clinically proven to have anti-inflammatory benefits.

Acne is reduced significantly following a course of treatments and skin texture and tone is improved as Energist pulsed light initiates further collagen production.

Technology

UK manufacturer Energist Medical Group produce a range of pulsed light systems, all of which are suitable for the effective, long term management of acne. Being at the forefront of this technology Energist has developed advanced technologies to maximise the comfort and effectiveness of the treatment.

UltraPlus VPL – Variable Pulsed Light

UltraPlus is a multi-application system using world renowned and patented Variable Pulsed Light VPL™ technology, only available from Energist Medical Group. This compact and versatile system offers the power and flexibility you need to achieve optimal clinical results for acne management. The careful filtering of the light from the specialist Acne applicator, and controlled delivery of the pulses means that UltraPlus is particularly safe and effective even on darker skin tones. Hair removal, skin rejuvenation, vascular applications, and the treatment of pigmented lesions are also possible using UltraPlus.

More information on UltraPlus VPL

ePulse – IPL

The ePulse system provides an effective solution for active acne. This portable and easy to use system with optional trolley from UK manufacturer Energist Medical Group is designed to provide high flexibility with exceptional performance. Using extended square pulse technology, ePulse offers comfort and versatility for acne management, hair removal, skin rejuvenation, and pigmentation treatments.

More information on ePulse

NeoGen – Plasma

NeoGen converts nitrogen gas into plasma energy, the fourth state of matter. The plasma emerges from the handpiece in controlled pulses, delivering heating to the skin and stimulating a significant physiological response, whilst leaving the skin intact.
In contrast to laser and light energy sources, NeoGen is allowing the nitrogen plasma energy to impact the skin’s entire architecture. With a wide range of energy settings available, treatments can be tailored to a patient’s specific needs and requirements in regards to healing time.

More information on NeoGen Spa and NeoGen PSR

Clinical

The following overviews detail the published clinical papers conducted by Energist’s clinical partners worldwide. Further studies currently underway will be added as they become available.

Please contact Energist for further information on any of these studies.


The treatment of Acne Vulgaris with Variable Pulsed Light (VPL™) using the Energist Ultra VPL™

Dr. med. Gebhard E. M. Gramlich, Chefarzt Privatklinik Hegenmühle GbR

Published in “Äesthetische Dermatologie” Issue 3 2006

This study was conducted in a very successful working medical aesthetic clinic in Southern Germany . Dr Gramlich was in search of an alternative therapy to offer to clients that were not responding to the routine acne treatments such as topical fruit acids, benzoyl peroxide and the most aggressive of all Roaccutane. When he saw the excellent results that he was achieving with the Ultra VPL™ system it was a great opportunity to share the data collected and provide a review of the causes and current treatments available for active acne.

“Altogether 80.64% of the cases achieved at least 70% improvement of the symptoms. 90.33% of the patients judged the result of the treatment as good and/or very good. The treatment with variable pulsed light is an outstanding method for the treatment of acne vulgaris at every level of severity. This therapy is important and valuable in the treatment of this dermatological complaint”


The use of VPL (Variable Pulsed Light) of Energist company in the treatment of acne vulgaris

Andrzej Kaszuba, Adam Halbina, Iwonna Michalak, Aleksandra Kaszuba, Centrum Medycze Dermed, Lodz, Klinika Dermatologii, Medical University, Wojewodzki Hospital, Lodz, Poland

Published in ‘Advances in Dermatology and Allergology, 2008

“The VPL treatment was performed once a week for the first three or four weeks and then, after improvement, once every two to four week, obtaining a significant reduction in the number of inflammatory eruptions with very good tolerance of the above treatment”


Treatment of Acne Scars Using the Plasma Skin Regeneration (PSR) System

Michele J. Gonzalez, MD,1 William H. Sturgill, MD,1 E. Victor Ross, MD,2 and Nathan S. Uebelhoer, DO 1,2

1Dermatology Department, Naval Medical Center San Diego, San Diego, California

2Scripps Clinic, Division of Dermatology, Cosmetic Dermatology Center, San Diego, California

Published in Lasers in Surgery and Medicine 40:124–127 (2008)

Excerpt: We report a blinded average of up to 41% improvement in facial acne scars 6 months after a single high-fluence treatment with the PSR system. While the magnitude of improvement that we observed in this study is not as dramatic as that seen with multi-pass ablative CO2 laser treatment, PSR offers several advantages.

First, the PSR is less operator dependent than traditional resurfacing.

Our study demonstrates that, even at high energy, double pass, the PSR requires minimal operator training to achieve predictable and safe effects with modest improvement in acne scars.

In contrast to aggressive ablative techniques, plasma regeneration maintains the integrity of the epidermis leading to less downtime, in terms of persistent erythema and wound care. Most patients are able to return to their typical social activities within 5-7 days after treatment and persistent facial erythema does not appear to be a significant risk. Furthermore, treatment may be performed in an office setting, avoiding the risks and costs associated with conscious sedation or general anesthesia that may be necessary with other treatments. Finally, since the PSR is an RF-induced nitrogen plasma device there are no special safety measures, such as protective eyewear, required.

One of the biggest issues with CO2 ablative resurfacing is the delayed-onset hypopigmentation, which can develop 18–24 months post-treatment. To our knowledge, there have been no reports of delayed hypopigmentation occurring with the PSR system.